# Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

> **NCT00479492** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 94 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** CP-866,087
- **DRUG:** CP-866,087
- **DRUG:** CP-866,087
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00479492
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2009-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479492, "Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00479492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*